Biotech

Notice of Paladin Labs' Third Quarter 2011 Results Conference Call

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 10/27/11 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, will release its third quarter 2011 financial results on Thursday, ...

Dynavax Reports Third Quarter 2011 Financial Results

BERKELEY, CA: BERKELEY, CA -- (Marketwire) -- 10/27/11 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the third quarter ended September 30, 2011, including $53.2 million in ...

Critical Outcome Technologies Inc. Reports Fiscal 2012 First Quarter Financial Results

LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 10/26/11 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced fiscal 2012 first quarter financial results today for the three month period end ...

Health Canada Clears Immunovaccine for Ovarian Cancer Vaccine Trials

HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwire) -- 10/26/11 -- Immunovaccine Inc. (TSX VENTURE: IMV) today announced that Health Canada has cleared its Clinical Trial Application (CTA) for a phase I/II study w ...

AVI BioPharma Announces Third Quarter 2011 Financial Results and Corporate Update Conference Call

BOTHELL, WA: BOTHELL, WA -- (Marketwire) -- 10/26/11 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, will report third quarter 2011 financial results after the NASDAQ Global Market ...

Octapharma Locks-in Binding Forecast to Exceed $2M for ProMetic's Prion Capture Resin for H1 2012

LAVAL, QUEBEC, CANADA AND CAMBRIDGE, UNITED KINGDOM: -Binding forecast in excess of $2 Million for the first 6 month of 2012 -New forecast incremental to $0.73 Million order announced earlier this month ...

GENEWIZ, Inc. Named Recipient of NJBIA Award for Excellence

SOUTH PLAINFIELD, NJ: SOUTH PLAINFIELD, NJ -- (Marketwire) -- 10/26/11 -- , the #1 provider of , as well as , , , and , was honored by the New Jersey Business & Industry Association (NJBIA) with the 2011 Award for Exc ...

Pacgen Appoints Dr. Ming S. Liu as CEO

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 10/25/11 -- Pacgen Biopharmaceuticals Corporation ("Pacgen" or the "Company") (TSX VENTURE: PGA) announced today that Ming S. Liu, ...

Cellceutix to File Investigational New Drug Application for Novel p53 Anti-Cancer Drug

BEVERLY, MA: Cellceutix Completes Clinical Protocol With Hosting Hospital; Receives Signed Forms Needed for Filing Investigational New Drug Application ...

Allon's CEO Presenting at BIO Investor Forum

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 10/25/11 -- (TSX: NPC) President and CEO, , will present an update of the Company's business progress on Wednesday, October 26 at the in San Fran ...